Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Interaction Map Value Type description Rank Network Comparison Type Gene red Filtered green network_comparison
Results: HTML CSV LaTeX Showing element 1775 to 1824 of 3228 in total
Interaction Map: High confidence
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent n-acetyltransferase 5 (ec 2.3.1.-). [source:swissprot;acc:q9y6d2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1161\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5315.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5782.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08783\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent n-deacetylase/n-sulfotransferase (heparan glucosaminyl) 3. [source:refseq;acc:nm\_004784]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 857\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5210.58\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5749.33\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.1034\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent n-deacetylase/n-sulfotransferase 4. [source:refseq;acc:nm\_022569]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 858\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent n-myc proto-oncogene protein. [source:swissprot;acc:p04198]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 451\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4889.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5610.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14745\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent n-terminal acetyltransferase complex ard1 subunit homolog (ec 2.3.1.-). [source:swissprot;acc:p41227]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 416\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4509.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5223.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.15842\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nadh-cytochrome b5 reductase (ec 1.6.2.2) (b5r). [source:swissprot;acc:p00387]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 917\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6289.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6911.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09893\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase 13 kda-a subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-13kd-a) (ci-13kd-a). [source:swissprot;acc:o75380]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 752\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4565.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5085.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11403\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase 13 kda-b subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-13kd-b) (ci-13kd-b) (complex i subunit b13). [source:swissprot;acc:q16718]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 3005\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase 18 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-18 kda) (ci-18 kda) (complex i- aqdq) (ci-aqdq). [source:swissprot;acc:o43181]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 75\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1920.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 2907.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.5137\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase 23 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-23kd) (ci-23kd) (tyky subunit). [source:swissprot;acc:o00217]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 457\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4890.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5610.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14731\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase 24 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3). [source:swissprot;acc:p19404]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2795\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase 30 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-30kd) (ci-30kd). [source:swissprot;acc:o75489]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 3081\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase 39 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-39kd) (ci-39kd). [source:swissprot;acc:q16795]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2954\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase 49 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-49kd) (ci-49kd). [source:swissprot;acc:o75306]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2878\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase b14 subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b14) (ci-b14). [source:swissprot;acc:p56556]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 589\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6739.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7644.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.13424\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase b22 subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b22) (ci-b22). [source:swissprot;acc:q9y6m9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 804\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6770.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7517.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11036\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase pdsw subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-pdsw) (ci-pdsw). [source:swissprot;acc:o96000]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1495\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6362.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6838.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07476\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase subunit b17.2 (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b17.2) (ci-b17.2) (cib17.2) (13 kda differentiation-associated protein). [source:swissprot;acc:q9ui09]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 66\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1991.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3221.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.61795\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nadph-cytochrome p450 reductase (ec 1.6.2.4) (cpr) (p450r). [source:swissprot;acc:p16435]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1845\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3591.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3375.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06417\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nadph:adrenodoxin oxidoreductase, mitochondrial precursor (ec 1.18.1.2) (adrenodoxin reductase) (ar) (ferredoxin-nadp(+) reductase). [source:swissprot;acc:p22570]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1110\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5947.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6481.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08979\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nag14 protein. [source:refseq;acc:nm\_022143]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1890\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5438.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5783.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06335\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nanos (fragment). [source:sptrembl;acc:q8wy41]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2803\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nardilysin precursor (ec 3.4.24.61) (n-arginine dibasic convertase) (nrd convertase) (nrd-c). [source:swissprot;acc:o43847]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1785\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5386.37\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5744.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06656\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nascent-polypeptide-associated complex alpha polypeptide. [source:refseq;acc:nm\_005594]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 703\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6912.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7735.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11899\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent necdin. [source:swissprot;acc:q99608]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 159\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 23693.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 18263\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.29736\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nefa-interacting nuclear protein nip30. [source:refseq;acc:nm\_024946]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1614\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6035.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6464.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07106\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent neighbor of cox4. [source:swissprot;acc:o43402]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1451\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5602.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6031.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07659\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent nemo-like kinase; likely ortholog of mouse nemo like kinase. [source:refseq;acc:nm\_016231]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1162\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5832.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6343.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0877\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent neural cell adhesion molecule l1 precursor (n-cam l1) (cd171 antigen). [source:swissprot;acc:p32004]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1661\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7433.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7950.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06953\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent neural wiskott-aldrich syndrome protein (n-wasp). [source:swissprot;acc:o00401]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 259\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6417.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7852.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.22355\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent neuralized-like. [source:refseq;acc:nm\_004210]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 65\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1657.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 2690.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.6229\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent neurocalcin delta. [source:swissprot;acc:p29554]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2210\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5258.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5517.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04908\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent neuroendocrine differentiation factor; comparative gene identification transcript 149. [source:refseq;acc:nm\_016079]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 149\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 11068\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8508.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.30082\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent neuroepithelial cell transforming gene 1; guanine nucleotide regulatory protein (oncogene); rho guanine nucleotide exchange factor (gef) 8. [source:refseq;acc:nm\_005863]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 745\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4086.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4557.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11527\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent neurogenic differentiation factor 1 (neurod1) (neurod). [source:swissprot;acc:q13562]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 50\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 779.167\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 1390.33\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.78438\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent neurogenic differentiation factor 2 (neurod2). [source:swissprot;acc:q15784]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 46\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent neurogenic differentiation factor 4 (neurod4). [source:swissprot;acc:q9hd90]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 51\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent neurogenic differentiation factor 6 (neurod6) (my051 protein). [source:swissprot;acc:q96nk8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 49\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent neuromedin u receptor 2. [source:refseq;acc:nm\_020167]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2991\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent neuron navigator 1; neuron navigator-1; pore membrane and/or filament interacting like protein 3. [source:refseq;acc:nm\_020443]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 492\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5979.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6842.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14429\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent neuron navigator 2 isoform l; retinoic acid inducible in neuroblastoma; pore membrane and/or filament interacting like protein 2; helicase helad1. [source:refseq;acc:nm\_145117]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 491\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5980.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6843.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14437\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent neuron navigator 3; pore membrane and/or filament interacting like protein 1; steerin 3. [source:refseq;acc:nm\_014903]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 493\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5979.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6842.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14429\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent neuron specific calcium-binding protein hippocalcin (p23k) (calcium- binding protein bdr-2). [source:swissprot;acc:p32076]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2209\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5259.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5517.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04908\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-2 chain precursor. [source:swissprot;acc:q15822]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 480\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 9649.61\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 11053.5\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.14549\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-3 chain precursor. [source:swissprot;acc:p32297]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 484\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-4 chain precursor. [source:swissprot;acc:p43681]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 483\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-6 chain precursor. [source:swissprot;acc:q15825]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 476\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-7 chain precursor. [source:swissprot;acc:p36544]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 399\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5201.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4479.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.16109\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent neuronal calcium sensor 1 (ncs-1) (frequenin homolog) (frequenin-like protein) (frequenin-like ubiquitous protein). [source:swissprot;acc:p36610]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2161\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5379.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5660\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.05218\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent neuronal kinesin heavy chain (nkhc) (kinesin heavy chain isoform 5a) (kinesin heavy chain neuron-specific 1). [source:swissprot;acc:q12840]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2045\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6036.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6379.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.05678\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/